We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Glycated Proteins and Oxidized Lipoproteins but Not Insulin Resistance Linked to CVD Risk

By LabMedica International staff writers
Posted on 22 Jul 2015
Heart disease researchers working with a pig model system identified glycated proteins and oxidized low-density lipoproteins (oxLDL) as biomarkers for cardiovascular disease (CVD) risk but did not find a similar association between CVD risk and insulin resistance.

Investigators at the University of North Carolina (Chapel Hill, USA) chose to work with pigs, since pigs, like humans, develop coronary artery and aortic atherosclerosis and insulin resistance. More...
In addition, pigs have been used in many studies to define the mechanisms that mediate increased atherosclerosis in diabetes.

In the current study, severity of coronary atherosclerosis was determined for 37 adult pigs (Sus scrofa) that had been fed a high fat diet that also contained high NaCl (56% above recommended levels) for one year.

Results published in the July 6, 2015, online edition of the journal PLOS One revealed that 20 pigs developed severe and diffuse distal coronary artery while the other 17 pigs had substantially less coronary artery atherosclerosis. All 37 pigs had blood pressure measurements in a range that would be considered hypertensive in humans and developed elevations in total, LDL, and HDL cholesterol, weight gain, increased backfat, and increased insulin resistance without overt diabetes. Five additional pigs fed regular pig chow also developed increased insulin resistance but essentially no change in the other variables and little to no detectible coronary atherosclerosis.

The 20 high fat/high NaCl diet-fed pigs with severe and diffuse distal coronary artery atherosclerosis had substantially greater increases in oxidized LDL and fructosamine consistent with increased protein glycation. Insulin resistance was not associated with atherosclerosis severity.

"If these correlations were also found in insulin resistant humans, then we would want to do everything we could to treat them because they would be at a very high risk of developing severe cardiovascular disease," said first author Dr. Timothy Nichols, professor of medicine and pathology at the University of North Carolina.

Related Links:
University of North Carolina



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.